Patent ID: 11912771
Assignee: CDR-LIFE AG
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC C

Claim 6:
7. An antigen binding protein that specifically recognizes a target Melanoma-Associated Antigen A4 (MAGE-A4) peptide-WIC (pMHC), comprising:
(a) an antibody heavy chain variable (VH) domain comprising an HCDR1 amino acid sequence of SNYAMS (SEQ ID NO: 469), an HCDR2 amino acid sequence of IVSSGGTTYYASWAKG (SEQ ID NO: 886), and an HCDR3 amino acid sequence of DLYYGPTTYSAANL (SEQ ID NO: 727); and
(b) an antibody light chain variable (VL) domain comprising an LCDR1 amino acid sequence of TADTLSRSYAS (SEQ ID NO: 472), an LCDR2 amino acid sequence of RDTSRPS (SEQ ID NO: 473), and an LCDR3 amino acid sequence of ATRDFSGSNFQL (SEQ ID NO: 875).